Thuraia Nageh

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 344 citations · Full text

Heart Failure, Intravenous Ferric Derisomaltose, Iron Metabolism +3

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 276 citations · Full text

Survival After Invasive or Conservative Management of Stable Coronary Disease

Judith S. Hochman, Rebecca Anthopolos, Harmony R. Reynolds et al. · Circulation · 2022 · 138 citations · Full text

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

Thuraia Nageh, Roy Sherwood, Beverly M. Harris et al. · International Journal of Cardiology · 2003 · 96 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Cardiac Troponin T +6

Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism

Andreas Wahl, Miranda Kunz, Aris Moschovitis et al. · Heart · 2007 · 79 citations